Contractile reserve and extent of transmural necrosis in the setting of myocardial stunning: Comparison at cardiac MR imaging

Radiology

Volumn 255, Issue 3, 2010, Pages 755-763

  Bodí, Vicente ^a   Husser, Oliver ^a,b   Sanchis, Juan ^a   Núñez, Julio ^a   López Lereu, María P ^c   Monmeneu, José V ^c   Mainar, Luis ^a   Chaustre, Fabian ^a   Riegger, Günter A J ^b   Bosch, María J ^a   Chorro, Francisco J ^a   Llácer, Angel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Hospital General Universitario Avda   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; TROPONIN I;

ADULT; AGED; ARTICLE; COMORBIDITY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE NECROSIS; HUMAN; KAPLAN MEIER METHOD; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; STUNNED HEART MUSCLE;

ANGIOPLASTY; AREA UNDER CURVE; CARDIOTONIC AGENTS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DOBUTAMINE; FEMALE; GADOLINIUM DTPA; HEART CATHETERIZATION; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL STUNNING; NECROSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RETREATMENT; STENTS;

EID: 77952719954     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10091191     Document Type: Article

References (19)

1. Bodí V, Sanchis J, López-Lereu MP, et al. Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol 2005;46(9):1747-1752.
2. Kramer CM, Rogers WJ Jr, Mankad S, Theobald TM, Pakstis DL, Hu YL. Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 2000;36(6):1835-1840.
3. Swinburn JM, Senior R. Myocardial viability assessed by dobutamine stress echocardiography predicts reduced mortality early after acute myocardial infarction: determining the risk of events after myocardial infarction(DREAM) study. Heart 2006;92(1):44-48.
4. Sicari R, Picano E, Landi P, et al. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative(EDIC) Study. J Am Coll Cardiol 1997;29(2):254-260.
5. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343(20):1445-1453.
6. Nijveldt R, Beek AM, Hirsch A, et al. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 2008;52(3):181-189. (Pubitemid 351915778)
7. Schuijf JD, Poldermans D, Shaw LJ, et al. Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging 2006;33(1):93-104.
8. Maceira AM, Prasad SK, Khan M, Pennell DJ. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2006;8(3):417-426.
9. Henriques JP, Zijlstra F, van 't Hof AW, et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 2003;107(16):2115-2119.
10. Schröder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation 2004;110(21):e506-e510.
11. Bodi V, Sanchis J, Lopez-Lereu MP, et al. Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol 2007;50(12):1174-1179.
12. Bodí V, Sanchis J, López-Lereu MP, et al. Microvascular perfusion 1 week and 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging. Heart 2006;92(12):1801- 1807.
13. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002;47(2):372-383.
14. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105(4):539-542.
15. Geskin G, Kramer CM, Rogers WJ, et al. Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 1998;98(3):217-223. (Pubitemid 28337612)
16. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004;109(18):2172-2174.
17. Barmeyer AA, Stork A, Bansmann M, et al. Prediction of myocardial recovery by dobutamine magnetic resonance imaging and delayed enhancement early after reperfused acute myocardial infarction. Eur Radiol 2008;18(1):110-118. (Pubitemid 351217282)
18. Bodi V, Sanchis J, Nunez J, et al. Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging 2009;2(7):835-842.
19. Wu E, Ortiz JT, Tejedor P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 2008;94(6):730-736.